This site is intended for US residents only
This site is intended for US residents only.
  •  
  • COMPANY ▾
    • TEVA GLOBAL
    • VISION + VALUES
    • HISTORY
    • SPECIALTY AREAS
      • CNS
      • Oncology
      • Respiratory
      • Select Brands
      • Women's Health
    • GOVERNMENT AFFAIRS
    • CONTACT
  • MEDICINES ▾
    • SPECIALTY MEDICINES
    • GENERIC MEDICINES
    • MEDICAL AFFAIRS
      • Medical Information
      • Medical Education
    • QUALITY + SAFETY
    • TRADE PARTNERS
      • Return Goods Policy
      • Terms and Conditions
      • ADR Products
  • RESPONSIBILITY ▾
    • CORPORATE SOCIAL RESPONSIBILITY
      • Corporate Charitable Donations
      • Access to Medicine
      • Volunteerism
    • ADVOCACY
    • COMPLIANCE
    • RELATIONSHIPS WITH HCPs
  • CAREERS ▾
    • SEARCH JOBS
    • CAREERS FAQ
    • THE TEVA EXPERIENCE
    • TESTIMONIALS
  • NEWS ▾
    • MEDIA CONTACTS
    • FAST FACTS
    • MEDIA FAQ
Who We Are Medicines Integrity Values Careers
Teva for your whole life.

TEVA PHARMACEUTICALS IN THE US

Teva is working every day to make quality healthcare accessible. As a manufacturer of specialty and generic pharmaceuticals, Teva provides both new and innovative therapies and greater access to affordable medicines.


Learn more ▸

MEDICINES THAT FIT EVERYONE'S NEEDS

One in every seven prescriptions dispensed in the US is a Teva product.*

*IMS Health NPA MAT June 2013


Explore Generics

▸


Explore All Medicines

▸

NEWS

4.17.14Teva Settles Patent Litigation with Pfizer on Celebrex®
4.15.14Teva Announces Launch of Generic Lunesta® Tablets in the United States
4.8.14Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the United States
3.31.14Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent
3.20.14Teva to Report First Quarter 2014 Financial Results on May 1, 2014
3.10.14Teva Pharmaceuticals and Volunteers in Medicine Partner to Expand Access to Healthcare in the U.S.
3.7.14Teva Announces Launch of Generic Xeloda® Tablets 150 MG and 500 MG in the United States
3.4.14Teva Announces Approval of Generic Evista® Tablets 60 mg in the United States
3.3.14Teva Launches ADASUVE® in U.S.
2.28.14Teva to Present at the Cowen & Company 34th Annual Healthcare Conference
More ▸
© Copyright 2014 Teva Pharmaceuticals USA
Supplier Portal   |   Privacy   |    Legal   |   Contact   |    Sitemap
COMPANY

 MEDICINES

 RESPONSIBILITY
TEVA GLOBAL

VISION + VALUES

HISTORY

SPECIALTY AREAS

GOVERNMENT
AFFAIRS

CONTACT 		SPECIALTY MEDICINES

GENERIC MEDICINES

MEDICAL AFFAIRS

QUALITY + SAFETY

TRADE PARTNERS 		CORPORATE SOCIAL
RESPONSIBILITY

ADVOCACY

COMPLIANCE

RELATIONSHIPS WITH HCPs
CAREERS

 NEWS
CAREERS FAQ

THE TEVA EXPERIENCE

TESTIMONIALS 		MEDIA CONTACTS

FAST FACTS

MEDIA FAQ